Eydenzelt is subjecting Eylea to further biosimilar erosion, though Regeneron hopes to offset this with two new approvals for ...

SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug ...

Canadians affected by the prescription drug Rexulti could receive a share of a $4.75-million class-action lawsuit settlement, ...

Robust growth is propelled by rising demand for regulatory writing, clinical documentation, and drug development. Medical ...

Mr. Dale has served as PharmaCorp’s Chief Operating Officer since its inception and will now take on broader leadership responsibilities as PharmaCorp advances its national expansion strategy. “Paul’s ...

Access to a vital therapy, known for treating adults with multiple myeloma, an incurable form of blood cancer, is being ...

Top stock picks from Sartorial Wealth’s Shiraz Ahmed using momentum and risk-adjusted analysis, including Royal Bank, ...

CNW/ - The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, has allocated $2.8 million CAD in funding ...

JAMAICA’S Senior Reggae Girlz ace goalkeeper Rebecca Spencer has exuded confidence in her team ahead of today’s FIFA Women’s ...

Memphis Grizzlies (8-12, 10th in the Western Conference) vs. Sacramento Kings (5-15, 13th in the Western Conference) ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ('Quantum BioPharma”), is pleased to announce that national television network CTV News’ flagship investigative program W5 has aired Part ...

Delmarva shipper Brutalizer will try to score his first win for his new connections in the $5,500 USD top conditioned trot on Saturday, Nov. 29 at First Tracks Cumberland ...